NCT00451152已完成2 期
A Study of the Safety and IOP-Lowering Efficacy of Anecortave Acetate in Patients With Open-Angle Glaucoma
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 89
- 试验地点
- 1
- 主要终点
- Mean Intraocular Pressure (IOP)
研究概览
简要总结
The purpose of this study was to evaluate the safety and intraocular pressure (IOP)-lowering efficacy of anecortave acetate for treatment of elevated IOP in patients with open-angle glaucoma.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of open-angle glaucoma;
- •Other protocol-defined inclusion criteria may apply.
排除标准
- •Pseudoexfoliation;
- •Pigment dispersion component;
- •Other protocol-defined exclusion criteria may apply.
研究组 & 干预措施
Anecortave Acetate Depot
Experimental
干预措施: Anecortave Acetate Sterile Suspension, 30 mg/mL (Drug)
Anecortave Acetate Vehicle
Placebo Comparator
干预措施: Anecortave Acetate Vehicle (Other)
结局指标
主要结局
Mean Intraocular Pressure (IOP)
时间窗: 3 months
次要结局
- Percent Treatment Failures(3 months)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Safety and Intraocular Pressure (IOP)-Lowering Efficacy of AL-39256 in Patients With Open-Angle Glaucoma or Ocular HypertensionOcular HypertensionOpen-Angle GlaucomaNCT00761709Alcon Research104
Unknown
2 期
Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Brimonidine TherapyGlaucomaNCT01345448Nanduri, Padma, M.D., FACS22
已完成
2 期
Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular HypertensionOular HypertensionOpen-angle GlaucomaNCT00691717Alcon Research201
已完成
不适用
Investigation of the iStent Inject® Devices in Open-Angle GlaucomaGlaucoma, Open-AngleNCT03624699Dr. Kaweh Mansouri42
Unknown
2 期
Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Latanoprost TherapyGlaucomaNCT01426464Nanduri, Padma, M.D., FACS22